Education
About Us
Working with TipRanks
Follow Us
Beijing Airdoc Technology Co. Ltd. Class H (HK:2251)
:2251
2251 Stock Chart & Stats
HK$12.44
-HK$0.02(-0.17%)
At close: 4:00 PM EST
HK$12.44
-HK$0.02(-0.17%)
Day’s Range― - ―
52-Week RangeHK$10.00 - HK$16.00
Previous CloseN/A
Volume16.00K
Average Volume (3M)61.23K
Market Cap
HK$1.22B
Enterprise ValueHK$526.79M
Total Cash (Recent Filing)HK$618.65M
Total Debt (Recent Filing)HK$12.71M
Price to Earnings (P/E)―
Beta0.69
Next Earnings
Mar 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding103,568,016
10 Day Avg. Volume99,440
30 Day Avg. Volume61,230
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)0.93
Price to Sales (P/S)7.56
P/FCF Ratio-7.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Equity PositionA high equity ratio indicates low financial leverage, providing stability and reducing financial risk, which is beneficial for long-term sustainability.
AI-Driven Healthcare SolutionsLeveraging AI in healthcare offers a competitive advantage by enhancing diagnostic accuracy and efficiency, positioning the company well in a growing market.
Subsidiary AcquisitionConsolidating the subsidiary could streamline operations and improve financial reporting, potentially leading to better strategic alignment and resource allocation.
Bears Say
Declining RevenueA substantial drop in revenue indicates challenges in market demand or competitive positioning, which could hinder growth and profitability.
Negative Cash FlowInability to generate positive cash flow raises sustainability concerns, limiting the company's ability to invest in growth and manage financial obligations.
Leadership ChangesFrequent leadership changes can disrupt strategic continuity and may affect the company's ability to execute long-term plans effectively.
Beijing Airdoc Technology Co. Ltd. Class H News
2251 FAQ
What was Beijing Airdoc Technology Co. Ltd. Class H’s price range in the past 12 months?
Beijing Airdoc Technology Co. Ltd. Class H lowest stock price was HK$10.00 and its highest was HK$16.00 in the past 12 months.
What is Beijing Airdoc Technology Co. Ltd. Class H’s market cap?
Beijing Airdoc Technology Co. Ltd. Class H’s market cap is HK$1.22B.
When is Beijing Airdoc Technology Co. Ltd. Class H’s upcoming earnings report date?
Beijing Airdoc Technology Co. Ltd. Class H’s upcoming earnings report date is Mar 26, 2026 which is in 31 days.
How were Beijing Airdoc Technology Co. Ltd. Class H’s earnings last quarter?
Beijing Airdoc Technology Co. Ltd. Class H released its earnings results on Aug 28, 2025. The company reported -HK$0.022 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.022.
Is Beijing Airdoc Technology Co. Ltd. Class H overvalued?
According to Wall Street analysts Beijing Airdoc Technology Co. Ltd. Class H’s price is currently Overvalued.
Does Beijing Airdoc Technology Co. Ltd. Class H pay dividends?
Beijing Airdoc Technology Co. Ltd. Class H does not currently pay dividends.
What is Beijing Airdoc Technology Co. Ltd. Class H’s EPS estimate?
Beijing Airdoc Technology Co. Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beijing Airdoc Technology Co. Ltd. Class H have?
Beijing Airdoc Technology Co. Ltd. Class H has 103,568,016 shares outstanding.
What happened to Beijing Airdoc Technology Co. Ltd. Class H’s price movement after its last earnings report?
Beijing Airdoc Technology Co. Ltd. Class H reported an EPS of -HK$0.022 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.285%.
Which hedge fund is a major shareholder of Beijing Airdoc Technology Co. Ltd. Class H?
Currently, no hedge funds are holding shares in HK:2251
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Beijing Airdoc Technology Co. Ltd. Class H Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
4.07%
12-Months-Change
Fundamentals
Return on Equity
-12.97%
Trailing 12-Months
Asset Growth
-9.50%
Trailing 12-Months
Company Description
Beijing Airdoc Technology Co. Ltd. Class H
Beijing Airdoc Technology Co., Ltd. provides AI-empowered retina-based early detection, diagnosis, and health risk assessment solutions for medical institutions and consumer healthcare providers in Mainland China and internationally. It offers Airdoc-AIFUNDUS (1.0), an AI-based software as a medical device for auxiliary diagnosis of diabetic retinopathy; Airdoc-AIFUNDUS (2.0) for the auxiliary diagnosis of hypertensive retinopathy, retinal vein occlusion, and age-related macular degeneration; and Airdoc-AIFUNDUS (3.0) for the auxiliary diagnosis of pathological myopia, retinal detachment, glaucoma detection, cataracts detection, ICVD/ASCVD, gestational diabetic retinopathy, gestational hypertensive retinopathy, papilledema intracranial, hypertension retinopathy, and anemia. The company also provides health risk assessment solutions to detect risk indicators, such as various lesions and diseases, hyperthyroidism, graves ophthalmopathy, retinal vein occlusion, dementia, Parkinson's disease, atrial fibrillation, and arteriosclerosis in a range of healthcare environments, including health checkup centers, community clinics, insurance companies, optometry centers, and pharmacies. In addition, it offers hardware devices, including fundus cameras. The company was incorporated in 2015 and is headquartered in Beijing, China.
Technical Analysis
Yidu Tech, Inc.
―
Chaoju Eye Care Holdings Ltd.
―
Yunkang Group Limited
―
C-MER Eye Care Holdings Limited
―
SinoMab Bioscience Ltd.
―